Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 3/20 | 0.45 |
| ▸ | BRD3 | Q15059 | 3/20 | 0.45 |
| ▸ | BRD2 | P25440 | 2/20 | 0.45 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.45 |
| ▸ | QPCT | Q16769 | 12/20 | 0.42 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22900334 | 0.88 | QPCT (0.42) | BRD4BRD3BRD2QPCT | |
| SCHEMBL22900601 | 0.88 | QPCT (0.51) | BRD4BRD3BRD2CREBBPQPCT | |
| SCHEMBL22900337 | 0.82 | BRD4 (0.45) | BRD4BRD3BRD2CREBBPQPCT | |
| SCHEMBL22900181 | 0.82 | QPCT (0.52) | BRD4BRD3BRD2CREBBPQPCT | |
| SCHEMBL22900335 | 0.81 | QPCT (0.42) | QPCT | |
| SCHEMBL22900541 | 0.81 | BRD4 (0.44) | BRD4BRD3BRD2CREBBPQPCT | |
| SCHEMBL22900731 | 0.80 | BRD4 (0.46) | BRD4BRD3BRD2CREBBPQPCT | |
| SCHEMBL22900249 | 0.79 | BRD4 (0.44) | BRD4BRD3BRD2CREBBPQPCT | |
| SCHEMBL22900517 | 0.77 | QPCT (0.52) | BRD4BRD3BRD2CREBBPQPCT | |
| SCHEMBL22900224 | 0.77 | QPCT (0.48) | BRD4BRD3BRD2CREBBPQPCT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021009068-A1 | N-SUBSTITUTED-3,4-(FUSED 5-RING)-5-PHENYL-PYRROLIDINE-2-ONE COMPOUNDS AS INHIBITORS OF ISOQC AND/OR QC ENZYME | SCENIC IMMUNOLOGY B.V. (NL) | 2021-01-21 | — | — | WO | disclosed |